"Die Zentralklinik Bad Berka gehört zu den modernsten und architektonisch schönsten Kliniken Deutschlands. Außerdem ist die Zentralklinik Akademisches Lehrkrankenhaus des Universitätsklinikums Jena. Als überregionales Schwerpunktversorgungskrankenhaus mit 21 Fachkliniken und Zentren sowie einem interdisziplinären Diagnostikum mit hochqualifizierten Ärzten und geschultem Pflegepersonal versorgen wir jährlich rund 43.000 Patienten aus ganz Deutschland und dem Ausland. Insgesamt verfügen wir in unserem landschaftlich reizvoll gelegenen Haus über 647 Planbetten. Die Zentralklinik ist mit ca. 1.800 Mitarbeitern der größte Arbeitgeber der Region Weimarer Land."

During the past decade, Zentralklinik Bad Berka GmbH conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 15 clinical trials were completed, i.e. on average, 48.4% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 8 clinical trials were completed. i.e. 72.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Zentralklinik Bad Berka GmbH" #1 sponsor was "Biotronik SE & Co. KG" with 6 trials, followed by "Abbott Medical Devices" with 5 trials sponsored, "University of Leipzig" with 4 trials sponsored, "Aeris Therapeutics" with 3 trials sponsored and "Boston Scientific Corporation" with 3 trials sponsored. Other sponsors include 47 different institutions and companies that sponsored additional 45 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Zentralklinik Bad Berka GmbH" #1 collaborator was "Medtronic" with 3 trials as a collaborator, "Guidant Corporation" with 2 trials as a collaborator, "Heart Center Leipzig - University Hospital" with 2 trials as a collaborator, "ABX CRO" with 1 trials as a collaborator and "Abbott Medical Devices" with 1 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Zentralklinik Bad Berka GmbH" are "Atrial Fibrillation" (5 trials), "Aortic Stenosis" (4 trials), "Carcinoma, Non-Small-Cell Lung" (4 trials), "Heart Failure" (4 trials) and "Myocardial Infarction" (4 trials). Many other conditions were trialed in "Zentralklinik Bad Berka GmbH" in a lesser frequency.

Most popular intervention types in "Zentralklinik Bad Berka GmbH" are "Device" (34 trials), "Drug" (22 trials), "Procedure" (7 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "ACURATE TA™ Transapical Aortic Bioprosthesis" (2 trials), "Amivantamab" (2 trials), "Best Supportive Care" (2 trials) and "Cardiac Resynchronization Therapy (CRT)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Zentralklinik Bad Berka GmbH" are 73 trials for "All" genders.

Currently, there are NaN active trials in "Zentralklinik Bad Berka GmbH". undefined are not yet recruiting, 8 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 45 completed trials in Zentralklinik Bad Berka GmbH, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Zentralklinik Bad Berka GmbH, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 14 trials that are defined as “Not Applicable".

Zentralklinik Bad Berka GmbH has several departments that took part in Clinical trials: "Zentralklinik Bad Berka GmbH; Pneumologie" - 6 trials, "Chefarzt Klinik für Pneumologie" - 2 trials, "Zentralklinik Bad Berka GmbH; Abteilung Onkologie und Hämatologie" - 2 trials